Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013886 |
---|---|
Receipt number | R000015990 |
Scientific Title | A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with trastuzumab for HER2-positive breast cancer |
Date of disclosure of the study information | 2014/05/06 |
Last modified on | 2016/05/11 10:02:17 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/05/06 10:46:44 | ||
2 | Update | 2016/05/11 10:02:17 | Name of primary person or sponsor Institute Organization Organization |